×
S&P 500   3,853.85 (+0.59%)
DOW   31,105.63 (+0.45%)
QQQ   289.21 (+0.78%)
AAPL   143.32 (+1.24%)
MSFT   266.84 (+1.52%)
META   169.40 (+0.72%)
GOOGL   2,283.79 (+0.82%)
AMZN   114.88 (+1.22%)
TSLA   694.58 (-0.66%)
NVDA   151.93 (+1.53%)
NIO   20.69 (-6.72%)
BABA   118.78 (-1.12%)
AMD   75.62 (+0.56%)
MU   57.68 (+1.67%)
CGC   2.67 (-1.48%)
T   21.19 (+0.09%)
GE   61.92 (-0.18%)
F   11.17 (-0.27%)
DIS   96.54 (-0.66%)
AMC   12.56 (-1.72%)
PFE   52.34 (+1.36%)
PYPL   73.56 (-1.13%)
NFLX   184.79 (-0.59%)
S&P 500   3,853.85 (+0.59%)
DOW   31,105.63 (+0.45%)
QQQ   289.21 (+0.78%)
AAPL   143.32 (+1.24%)
MSFT   266.84 (+1.52%)
META   169.40 (+0.72%)
GOOGL   2,283.79 (+0.82%)
AMZN   114.88 (+1.22%)
TSLA   694.58 (-0.66%)
NVDA   151.93 (+1.53%)
NIO   20.69 (-6.72%)
BABA   118.78 (-1.12%)
AMD   75.62 (+0.56%)
MU   57.68 (+1.67%)
CGC   2.67 (-1.48%)
T   21.19 (+0.09%)
GE   61.92 (-0.18%)
F   11.17 (-0.27%)
DIS   96.54 (-0.66%)
AMC   12.56 (-1.72%)
PFE   52.34 (+1.36%)
PYPL   73.56 (-1.13%)
NFLX   184.79 (-0.59%)
S&P 500   3,853.85 (+0.59%)
DOW   31,105.63 (+0.45%)
QQQ   289.21 (+0.78%)
AAPL   143.32 (+1.24%)
MSFT   266.84 (+1.52%)
META   169.40 (+0.72%)
GOOGL   2,283.79 (+0.82%)
AMZN   114.88 (+1.22%)
TSLA   694.58 (-0.66%)
NVDA   151.93 (+1.53%)
NIO   20.69 (-6.72%)
BABA   118.78 (-1.12%)
AMD   75.62 (+0.56%)
MU   57.68 (+1.67%)
CGC   2.67 (-1.48%)
T   21.19 (+0.09%)
GE   61.92 (-0.18%)
F   11.17 (-0.27%)
DIS   96.54 (-0.66%)
AMC   12.56 (-1.72%)
PFE   52.34 (+1.36%)
PYPL   73.56 (-1.13%)
NFLX   184.79 (-0.59%)
S&P 500   3,853.85 (+0.59%)
DOW   31,105.63 (+0.45%)
QQQ   289.21 (+0.78%)
AAPL   143.32 (+1.24%)
MSFT   266.84 (+1.52%)
META   169.40 (+0.72%)
GOOGL   2,283.79 (+0.82%)
AMZN   114.88 (+1.22%)
TSLA   694.58 (-0.66%)
NVDA   151.93 (+1.53%)
NIO   20.69 (-6.72%)
BABA   118.78 (-1.12%)
AMD   75.62 (+0.56%)
MU   57.68 (+1.67%)
CGC   2.67 (-1.48%)
T   21.19 (+0.09%)
GE   61.92 (-0.18%)
F   11.17 (-0.27%)
DIS   96.54 (-0.66%)
AMC   12.56 (-1.72%)
PFE   52.34 (+1.36%)
PYPL   73.56 (-1.13%)
NFLX   184.79 (-0.59%)
OTCMKTS:CBDL

CBD Life Sciences Stock Forecast, Price & News

$0.0002
0.00 (0.00%)
(As of 07/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range
N/A
52-Week Range
$0.00
$0.00
Volume
64.23 million shs
Average Volume
76.56 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CBD Life Sciences MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.22 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive CBDL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CBD Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

About CBD Life Sciences

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

CBDL Stock News Headlines

CBD Life Sciences launches new lab at CBD Vault
LBC Bioscience
CBD Life Sciences to start production of HHC products
See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers-Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CBDL
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A














CBD Life Sciences Frequently Asked Questions

How has CBD Life Sciences' stock price performed in 2022?

CBD Life Sciences' stock was trading at $0.0002 at the beginning of 2022. Since then, CBDL stock has increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2022 here
.

Are investors shorting CBD Life Sciences?

CBD Life Sciences saw a decline in short interest in May. As of May 31st, there was short interest totaling 800 shares, a decline of 93.4% from the May 15th total of 12,200 shares. Based on an average daily volume of 113,948,200 shares, the days-to-cover ratio is presently 0.0 days.
View CBD Life Sciences' Short Interest
.

Who are CBD Life Sciences' key executives?

CBD Life Sciences' management team includes the following people:
  • Ms. Lisa Anne Nelson, Pres, CEO, CFO & Director (Age 55, Pay $240k)
  • Ms. Vicki Martinez, Sec. & Director
  • Ms. Mercedes Sturm, Treasurer & Director

What is CBD Life Sciences' stock symbol?

CBD Life Sciences trades on the OTCMKTS under the ticker symbol "CBDL."

How do I buy shares of CBD Life Sciences?

Shares of CBDL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CBD Life Sciences' stock price today?

One share of CBDL stock can currently be purchased for approximately $0.00.

How many employees does CBD Life Sciences have?

CBD Life Sciences employs 7 workers across the globe.

How can I contact CBD Life Sciences?

The official website for CBD Life Sciences is www.optiumcyber.com. The company can be reached via phone at (480) 410-6780.

This page (OTCMKTS:CBDL) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.